| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $83K | -90.6% |
| R&D Expense | $9.3M | +51.3% |
| SG&A Expense | $6.0M | +11.7% |
| Operating Income | -$19.2M | -80.6% |
| Pre-tax Income | -$19.4M | -81.6% |
| Income Tax | $8K | +125.1% |
| Net Income | -$19.4M | -82.2% |
| EPS (Basic) | -$9.19 | -3303.7% |
| EPS (Diluted) | -$9.19 | -3303.7% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $9.1M | -46.0% |
| Current Assets | $9.8M | -42.7% |
| Total Assets | $10.3M | -42.6% |
| Current Liabilities | $5.0M | +20.3% |
| Total Liabilities | $5.0M | +8.8% |
| Stockholders' Equity | $5.2M | -60.5% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$15.9M | -70.2% |
| Capital Expenditures | $7K | -60.2% |
| Investing Cash Flow | -$7K | +60.2% |
| Financing Cash Flow | $8.1M | -48.5% |
| Free Cash Flow | -$15.9M | -70.0% |